Literature DB >> 14622208

Interleukin 1 beta enhances conditioned fear memory in rats: possible involvement of glucocorticoids.

Cai Song1, Anthony G Phillips, Brian Leonard.   

Abstract

Central administration of 15 ng interleukin (IL)-1beta in the rat significantly enhanced conditioned fear memory assessed by a passive avoidance task, when retested at 24 and 48 h post-training. Pain threshold was unaffected by 15 ng IL-1beta administration. IL-1beta treatment also increased serum corticosterone. This increase in serum corticosterone was further enhanced in rats given both IL-1beta and footshock. Furthermore, the glucocorticoid receptor antagonist mifepristone blocked IL-1beta-induced elevation in corticosterone and also attenuated the enhanced conditioned fear memory. Central administration of IL-1beta significantly increased prostaglandin E2 and decreased the anti-inflammatory cytokine IL-10 release from whole blood cultures; therefore this treatment appears to be effective in inducing an inflammatory response in both the periphery and the brain. The present study confirms that IL-1beta can enhance conditioned fear memory, an effect which is correlated with changes in glucocorticoid function. This facilitation of defensive behaviour could reflect adaptive responses which may enhance survival during sickness.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14622208     DOI: 10.1046/j.1460-9568.2003.02886.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  19 in total

Review 1.  Modulation of learning and memory by cytokines: signaling mechanisms and long term consequences.

Authors:  Elissa J Donzis; Natalie C Tronson
Journal:  Neurobiol Learn Mem       Date:  2014-08-21       Impact factor: 2.877

Review 2.  Autonomic and inflammatory consequences of posttraumatic stress disorder and the link to cardiovascular disease.

Authors:  Chevelle Brudey; Jeanie Park; Jan Wiaderkiewicz; Ihori Kobayashi; Thomas A Mellman; Paul J Marvar
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-06-10       Impact factor: 3.619

3.  Mangiferin decreases inflammation and oxidative damage in rat brain after stress.

Authors:  Lucía Márquez; Borja García-Bueno; José L M Madrigal; Juan C Leza
Journal:  Eur J Nutr       Date:  2011-10-07       Impact factor: 5.614

Review 4.  Alterations in immune cells and mediators in the brain: it's not always neuroinflammation!

Authors:  Myka L Estes; A Kimberley McAllister
Journal:  Brain Pathol       Date:  2014-11       Impact factor: 6.508

Review 5.  Interleukin-1β with learning and memory.

Authors:  Zhen-Bo Huang; Guo-Qing Sheng
Journal:  Neurosci Bull       Date:  2010-12       Impact factor: 5.203

6.  Central glucocorticoid receptors modulate the expression and function of spinal NMDA receptors after peripheral nerve injury.

Authors:  Shuxing Wang; Grewo Lim; Qing Zeng; Backil Sung; Liling Yang; Jianren Mao
Journal:  J Neurosci       Date:  2005-01-12       Impact factor: 6.167

7.  Regulation of the trigeminal NR1 subunit expression induced by inflammation of the temporomandibular joint region in rats.

Authors:  Shuxing Wang; Grewo Lim; Ji Mao; Backil Sung; Jianren Mao
Journal:  Pain       Date:  2008-12-05       Impact factor: 6.961

Review 8.  Chronic treatment with anti-bipolar drugs causes intracellular alkalinization in astrocytes, altering their functions.

Authors:  Dan Song; Baoman Li; Enzhi Yan; Yi Man; Marina Wolfson; Ye Chen; Liang Peng
Journal:  Neurochem Res       Date:  2012-07-28       Impact factor: 3.996

Review 9.  A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder.

Authors:  Rushaniya A Khairova; Rodrigo Machado-Vieira; Jing Du; Husseini K Manji
Journal:  Int J Neuropsychopharmacol       Date:  2009-02-19       Impact factor: 5.176

Review 10.  Role of neuro-immunological factors in the pathophysiology of mood disorders.

Authors:  Anindya Bhattacharya; Noel C Derecki; Timothy W Lovenberg; Wayne C Drevets
Journal:  Psychopharmacology (Berl)       Date:  2016-01-23       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.